France’s Sanofi Still Sees COVID-19 Phase 3 Trial Completed In Q1
By Gwladys Fouche PARIS (Reuters) – French drugmaker Sanofi said it still expected its COVID-19 vaccine to complete phase 3 trial in the first quarter and reported a rise in fourth-quarter sales and earnings on Friday. The group, which is hoping for a comeback after losing ground in the COVID-19 jab race, also said it…